nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—ADRB1—dilated cardiomyopathy	0.281	0.358	CbGaD
Pseudoephedrine—TNF—dilated cardiomyopathy	0.266	0.34	CbGaD
Pseudoephedrine—ADRB2—dilated cardiomyopathy	0.236	0.301	CbGaD
Pseudoephedrine—Prostatic hypertrophy—Furosemide—dilated cardiomyopathy	0.0185	0.212	CcSEcCtD
Pseudoephedrine—Acute retention of urine—Furosemide—dilated cardiomyopathy	0.0166	0.191	CcSEcCtD
Pseudoephedrine—Benign prostatic hyperplasia—Furosemide—dilated cardiomyopathy	0.01	0.115	CcSEcCtD
Pseudoephedrine—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.00343	0.243	CbGeAlD
Pseudoephedrine—NFATC1—heart—dilated cardiomyopathy	0.00247	0.175	CbGeAlD
Pseudoephedrine—IL2—heart—dilated cardiomyopathy	0.00226	0.16	CbGeAlD
Pseudoephedrine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00171	0.0196	CcSEcCtD
Pseudoephedrine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00156	0.0179	CcSEcCtD
Pseudoephedrine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00134	0.0154	CcSEcCtD
Pseudoephedrine—Irritability—Furosemide—dilated cardiomyopathy	0.00121	0.0139	CcSEcCtD
Pseudoephedrine—Urinary retention—Furosemide—dilated cardiomyopathy	0.0012	0.0138	CcSEcCtD
Pseudoephedrine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00117	0.0134	CcSEcCtD
Pseudoephedrine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00115	0.0132	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000941	0.0108	CcSEcCtD
Pseudoephedrine—Sweating—Furosemide—dilated cardiomyopathy	0.000934	0.0107	CcSEcCtD
Pseudoephedrine—Irritability—Lisinopril—dilated cardiomyopathy	0.000905	0.0104	CcSEcCtD
Pseudoephedrine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000902	0.0104	CcSEcCtD
Pseudoephedrine—ADRB1—cardiac ventricle—dilated cardiomyopathy	0.000862	0.0612	CbGeAlD
Pseudoephedrine—ADRB1—myocardium—dilated cardiomyopathy	0.000811	0.0575	CbGeAlD
Pseudoephedrine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000798	0.00917	CcSEcCtD
Pseudoephedrine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000781	0.00897	CcSEcCtD
Pseudoephedrine—Dysuria—Lisinopril—dilated cardiomyopathy	0.000766	0.0088	CcSEcCtD
Pseudoephedrine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000755	0.00867	CcSEcCtD
Pseudoephedrine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000732	0.0084	CcSEcCtD
Pseudoephedrine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000726	0.00834	CcSEcCtD
Pseudoephedrine—Rash—Spironolactone—dilated cardiomyopathy	0.00072	0.00827	CcSEcCtD
Pseudoephedrine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000719	0.00826	CcSEcCtD
Pseudoephedrine—Headache—Spironolactone—dilated cardiomyopathy	0.000715	0.00821	CcSEcCtD
Pseudoephedrine—Sweating—Lisinopril—dilated cardiomyopathy	0.0007	0.00804	CcSEcCtD
Pseudoephedrine—Agitation—Furosemide—dilated cardiomyopathy	0.000699	0.00803	CcSEcCtD
Pseudoephedrine—Vertigo—Furosemide—dilated cardiomyopathy	0.000684	0.00785	CcSEcCtD
Pseudoephedrine—Nausea—Spironolactone—dilated cardiomyopathy	0.000678	0.00779	CcSEcCtD
Pseudoephedrine—MAOA—cardiac ventricle—dilated cardiomyopathy	0.000676	0.0479	CbGeAlD
Pseudoephedrine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000668	0.00767	CcSEcCtD
Pseudoephedrine—Hallucination—Lisinopril—dilated cardiomyopathy	0.000653	0.0075	CcSEcCtD
Pseudoephedrine—Phenylpropanolamine—ADRB1—dilated cardiomyopathy	0.000644	0.213	CrCbGaD
Pseudoephedrine—Amphetamine—SLC22A5—dilated cardiomyopathy	0.000639	0.212	CrCbGaD
Pseudoephedrine—MAOA—myocardium—dilated cardiomyopathy	0.000635	0.0451	CbGeAlD
Pseudoephedrine—Confusional state—Furosemide—dilated cardiomyopathy	0.000626	0.00719	CcSEcCtD
Pseudoephedrine—Ephedrine—ADRB2—dilated cardiomyopathy	0.000603	0.2	CrCbGaD
Pseudoephedrine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.0006	0.0069	CcSEcCtD
Pseudoephedrine—Anorexia—Furosemide—dilated cardiomyopathy	0.000592	0.0068	CcSEcCtD
Pseudoephedrine—Methamphetamine—SLC22A5—dilated cardiomyopathy	0.000592	0.196	CrCbGaD
Pseudoephedrine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000586	0.00673	CcSEcCtD
Pseudoephedrine—ADRB1—heart—dilated cardiomyopathy	0.000566	0.0402	CbGeAlD
Pseudoephedrine—Tension—Lisinopril—dilated cardiomyopathy	0.00056	0.00643	CcSEcCtD
Pseudoephedrine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000555	0.00637	CcSEcCtD
Pseudoephedrine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000549	0.0063	CcSEcCtD
Pseudoephedrine—Phenylpropanolamine—ADRB2—dilated cardiomyopathy	0.000541	0.179	CrCbGaD
Pseudoephedrine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00054	0.0062	CcSEcCtD
Pseudoephedrine—Tremor—Lisinopril—dilated cardiomyopathy	0.000535	0.00614	CcSEcCtD
Pseudoephedrine—Pain—Furosemide—dilated cardiomyopathy	0.000531	0.0061	CcSEcCtD
Pseudoephedrine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000513	0.00589	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000512	0.00588	CcSEcCtD
Pseudoephedrine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000505	0.0058	CcSEcCtD
Pseudoephedrine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000491	0.00564	CcSEcCtD
Pseudoephedrine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000486	0.00558	CcSEcCtD
Pseudoephedrine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000484	0.00556	CcSEcCtD
Pseudoephedrine—ADRB1—cardiac atrium—dilated cardiomyopathy	0.000484	0.0344	CbGeAlD
Pseudoephedrine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00047	0.0054	CcSEcCtD
Pseudoephedrine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000455	0.00522	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00045	0.00517	CcSEcCtD
Pseudoephedrine—ADRA1A—heart—dilated cardiomyopathy	0.000448	0.0318	CbGeAlD
Pseudoephedrine—Asthenia—Furosemide—dilated cardiomyopathy	0.000446	0.00512	CcSEcCtD
Pseudoephedrine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000444	0.0051	CcSEcCtD
Pseudoephedrine—MAOA—heart—dilated cardiomyopathy	0.000444	0.0315	CbGeAlD
Pseudoephedrine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000421	0.00484	CcSEcCtD
Pseudoephedrine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000415	0.00477	CcSEcCtD
Pseudoephedrine—Dizziness—Furosemide—dilated cardiomyopathy	0.000411	0.00472	CcSEcCtD
Pseudoephedrine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00041	0.00471	CcSEcCtD
Pseudoephedrine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000405	0.00465	CcSEcCtD
Pseudoephedrine—Pain—Lisinopril—dilated cardiomyopathy	0.000398	0.00458	CcSEcCtD
Pseudoephedrine—Vomiting—Furosemide—dilated cardiomyopathy	0.000395	0.00454	CcSEcCtD
Pseudoephedrine—Rash—Furosemide—dilated cardiomyopathy	0.000392	0.0045	CcSEcCtD
Pseudoephedrine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000391	0.00449	CcSEcCtD
Pseudoephedrine—Headache—Furosemide—dilated cardiomyopathy	0.000389	0.00447	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000384	0.00441	CcSEcCtD
Pseudoephedrine—MAOA—cardiac atrium—dilated cardiomyopathy	0.000379	0.0269	CbGeAlD
Pseudoephedrine—Nausea—Furosemide—dilated cardiomyopathy	0.000369	0.00424	CcSEcCtD
Pseudoephedrine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000368	0.00423	CcSEcCtD
Pseudoephedrine—ADRA2A—heart—dilated cardiomyopathy	0.00034	0.0241	CbGeAlD
Pseudoephedrine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000334	0.00384	CcSEcCtD
Pseudoephedrine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000308	0.00354	CcSEcCtD
Pseudoephedrine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000296	0.0034	CcSEcCtD
Pseudoephedrine—Rash—Lisinopril—dilated cardiomyopathy	0.000294	0.00337	CcSEcCtD
Pseudoephedrine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000294	0.00337	CcSEcCtD
Pseudoephedrine—Headache—Lisinopril—dilated cardiomyopathy	0.000292	0.00335	CcSEcCtD
Pseudoephedrine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.000291	0.0207	CbGeAlD
Pseudoephedrine—Nausea—Lisinopril—dilated cardiomyopathy	0.000277	0.00318	CcSEcCtD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	7.22e-05	0.000639	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.21e-05	0.000638	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD36—dilated cardiomyopathy	7.21e-05	0.000638	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ITGB1—dilated cardiomyopathy	7.15e-05	0.000633	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	7.05e-05	0.000624	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.99e-05	0.000618	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TAZ—dilated cardiomyopathy	6.96e-05	0.000616	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.93e-05	0.000613	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.86e-05	0.000607	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—RAC1—dilated cardiomyopathy	6.8e-05	0.000601	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.79e-05	0.000601	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.79e-05	0.000601	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	6.71e-05	0.000594	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.71e-05	0.000594	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	6.71e-05	0.000593	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	6.71e-05	0.000593	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.65e-05	0.000588	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.65e-05	0.000588	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.62e-05	0.000586	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.56e-05	0.000581	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.56e-05	0.000581	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	6.53e-05	0.000578	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.51e-05	0.000576	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	6.5e-05	0.000575	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	6.48e-05	0.000573	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—VCL—dilated cardiomyopathy	6.41e-05	0.000567	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.32e-05	0.000559	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SDHA—dilated cardiomyopathy	6.3e-05	0.000557	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.29e-05	0.000557	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—RAC1—dilated cardiomyopathy	6.28e-05	0.000555	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.23e-05	0.000552	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.18e-05	0.000547	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	6.15e-05	0.000544	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.1e-05	0.00054	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD36—dilated cardiomyopathy	6.1e-05	0.00054	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	6.04e-05	0.000534	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	6.02e-05	0.000533	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—AGT—dilated cardiomyopathy	6.01e-05	0.000532	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.98e-05	0.000529	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.97e-05	0.000528	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—EGFR—dilated cardiomyopathy	5.94e-05	0.000526	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.91e-05	0.000523	CbGpPWpGaD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	5.9e-05	0.000522	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	5.9e-05	0.000522	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—RAC1—dilated cardiomyopathy	5.75e-05	0.000509	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	5.71e-05	0.000505	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.66e-05	0.000501	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.55e-05	0.000491	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	5.5e-05	0.000486	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	5.5e-05	0.000486	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	5.39e-05	0.000477	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	5.32e-05	0.000471	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—EGFR—dilated cardiomyopathy	5.31e-05	0.000469	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	5.27e-05	0.000467	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	5.27e-05	0.000466	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.24e-05	0.000464	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.22e-05	0.000462	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—ITGB1—dilated cardiomyopathy	5.17e-05	0.000458	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.16e-05	0.000456	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.11e-05	0.000452	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	5.11e-05	0.000452	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	5.11e-05	0.000452	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	5.11e-05	0.000452	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.05e-05	0.000447	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	5.02e-05	0.000444	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	5.01e-05	0.000444	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.96e-05	0.000438	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	4.95e-05	0.000438	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	4.95e-05	0.000438	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	4.89e-05	0.000433	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.86e-05	0.00043	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.83e-05	0.000427	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.79e-05	0.000424	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	4.75e-05	0.00042	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.72e-05	0.000418	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	4.65e-05	0.000411	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	4.6e-05	0.000407	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	4.56e-05	0.000404	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—RAF1—dilated cardiomyopathy	4.51e-05	0.000399	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	4.48e-05	0.000396	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—CD36—dilated cardiomyopathy	4.41e-05	0.00039	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.39e-05	0.000389	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	4.3e-05	0.00038	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.23e-05	0.000374	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	4.21e-05	0.000372	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AGT—dilated cardiomyopathy	4.2e-05	0.000371	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.17e-05	0.000369	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—RAF1—dilated cardiomyopathy	4.16e-05	0.000368	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—RAC1—dilated cardiomyopathy	4.16e-05	0.000368	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—RAF1—dilated cardiomyopathy	4.13e-05	0.000366	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.11e-05	0.000364	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.04e-05	0.000358	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.01e-05	0.000355	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	3.93e-05	0.000347	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.91e-05	0.000346	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—RAF1—dilated cardiomyopathy	3.84e-05	0.00034	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.84e-05	0.00034	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.84e-05	0.00034	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—RAF1—dilated cardiomyopathy	3.81e-05	0.000337	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.76e-05	0.000332	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.76e-05	0.000332	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	3.73e-05	0.00033	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—RAC1—dilated cardiomyopathy	3.72e-05	0.000329	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	3.68e-05	0.000325	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	3.66e-05	0.000324	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.63e-05	0.000321	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	3.6e-05	0.000318	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.57e-05	0.000316	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AGT—dilated cardiomyopathy	3.55e-05	0.000314	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.49e-05	0.000309	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.49e-05	0.000308	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.49e-05	0.000308	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.41e-05	0.000302	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.41e-05	0.000302	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.38e-05	0.000299	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	3.33e-05	0.000294	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.24e-05	0.000287	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	3.22e-05	0.000285	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	3.22e-05	0.000285	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.17e-05	0.00028	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.11e-05	0.000275	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.11e-05	0.000275	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—EGFR—dilated cardiomyopathy	3.09e-05	0.000273	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.07e-05	0.000272	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	3.03e-05	0.000268	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	2.97e-05	0.000263	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.95e-05	0.000261	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.91e-05	0.000258	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.89e-05	0.000255	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.89e-05	0.000255	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.89e-05	0.000255	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.89e-05	0.000255	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.86e-05	0.000253	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—EGFR—dilated cardiomyopathy	2.85e-05	0.000252	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.82e-05	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.82e-05	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.8e-05	0.000248	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.8e-05	0.000247	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	2.76e-05	0.000244	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—RAF1—dilated cardiomyopathy	2.76e-05	0.000244	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	2.74e-05	0.000243	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.74e-05	0.000242	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.68e-05	0.000237	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.68e-05	0.000237	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.62e-05	0.000232	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.62e-05	0.000232	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.62e-05	0.000232	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.62e-05	0.000232	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—EGFR—dilated cardiomyopathy	2.61e-05	0.000231	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.6e-05	0.00023	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	2.59e-05	0.000229	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.54e-05	0.000225	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.54e-05	0.000225	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	2.51e-05	0.000222	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.46e-05	0.000218	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.44e-05	0.000216	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.39e-05	0.000211	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.36e-05	0.000209	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.33e-05	0.000206	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.32e-05	0.000205	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.27e-05	0.000201	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.27e-05	0.0002	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.22e-05	0.000196	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.17e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.17e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.13e-05	0.000188	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.11e-05	0.000186	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.08e-05	0.000184	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.07e-05	0.000183	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.06e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.06e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.06e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.03e-05	0.00018	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.02e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.01e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.01e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EGFR—dilated cardiomyopathy	2e-05	0.000177	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.97e-05	0.000175	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.93e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.91e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.91e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EGFR—dilated cardiomyopathy	1.89e-05	0.000167	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.89e-05	0.000167	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.88e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.87e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.85e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.81e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.76e-05	0.000156	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.74e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	1.71e-05	0.000152	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GPX1—dilated cardiomyopathy	1.71e-05	0.000151	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.69e-05	0.00015	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.68e-05	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.67e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.67e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CD36—dilated cardiomyopathy	1.67e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.63e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.6e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.58e-05	0.00014	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.56e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.55e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.55e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.55e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.55e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.53e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.5e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.5e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AGT—dilated cardiomyopathy	1.5e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.48e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.44e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.42e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.39e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.31e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.29e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.28e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.28e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.26e-05	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.22e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.19e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.17e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	1.14e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.14e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.13e-05	9.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.11e-05	9.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	1.11e-05	9.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.09e-05	9.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.06e-05	9.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.04e-05	9.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	1e-05	8.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.84e-06	8.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.71e-06	8.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	9.44e-06	8.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	9.02e-06	7.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.98e-06	7.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.78e-06	7.77e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	8.77e-06	7.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	8.38e-06	7.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.73e-06	6.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.57e-06	6.69e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	7.45e-06	6.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.26e-06	6.43e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	7.25e-06	6.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.75e-06	5.97e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	6.53e-06	5.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	6.26e-06	5.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.81e-06	5.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.3e-06	4.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	5.19e-06	4.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.29e-06	3.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.99e-06	3.53e-05	CbGpPWpGaD
